| Application no. and date | 19167051.2 (espacenet) (Federated) (European Patent Register), 20160518 | | Patent/reg. no. and date | DK/EP 3527574, 20220406 | | Publication date | 20190821 | | Priority no. and date | US 201562163188 P, 20150518 | | EP pub. no. and date |
EP 3527574 20190821 | | Effective date | | | Applicant/owner | Sumitomo Pharma Oncology, Inc., 84 Waterford Drive
Marlborough, MA 01752, US | | Applicant ref. no. | P80076DK01 | | Inventor | SIDDIQUI-JAIN, Adam, 11643 South Jordan Farms Road
South Jordan, Utah 84095, US,
BEARSS, David J., 1287 E. Capman Court
Alpine, Utah 84004, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/661 (2006.01) , A61P 35/00 (2006.01) , C07F 9/12 (2006.01) | | Title | ALVOCIDIB-PRODRUGS, DER HAR ØGET BIOTILGÆNGELIGHED | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
